Robyn Domsic is a Rheumatology/Immunology physician affiliated with UPMC Health System. OpenAlex indexes 173 publications with 6,313 citations (h-index 42); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3601 5th Ave
Suite 2b Falk Medical Building
Pittsburgh, PA 152133403
Telephone
412-647-6700Registry record last updated 24 May 2021.
Clinical trials
- The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life
Sponsor: Robyn T. Domsic, MD, MPH
- Apollo Device for Fatigue in Systemic Sclerosis
Sponsor: Robyn T. Domsic, MD, MPH
- Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20251 payment
- E.R. Squibb & Sons, L.L.C.Program year20251 payment
- AstraZeneca UK LimitedProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
31.5%Proton pump inhibitor13.2%Omeprazole47%Pantoprazole Sodium29%Esomeprazole Magnesium16%Dexlansoprazole Dr8%Part D<11 patientsCorticosteroid8.1%Prednisone100%Part D≥24 patients+ 2 more classes in this area
Nervous system
19.8%Gabapentinoids9.7%Gabapentin100%Part D≥19 patientsSSRI6%Fluoxetine Hcl82%Escitalopram Oxalate18%Part D<11 patients+ 3 more classes in this area
Antiparasitic
19.5%Antimalarial19.5%Hydroxychloroquine Sulfate100%Part D≥66 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
7 NIH research awards on record, funded 2009–2026 per NIH RePORTER. The latest:
- Transforming Autoimmune Diagnostic and Disease Monitoring with a Scalable IP-to-MS Platform for Autoantigen Profiling
Impact Proteomics, Llc
FY2026$320,863R43AI197429
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Vishal Jhanji, MD
UPMC Health System
Carolyn Willis
UPMC Health System
Devereux Saller
UPMC Health System
Richard Redlinger, MD
UPMC Health System
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”